Effect of Ischemia Reperfusion Injury and Epoxyeicosatrienoic Acids on Caveolin Expression in Mouse Myocardium
- 1 March 2013
- journal article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 61 (3) , 258-263
Abstract
Caveolins (Cav) are structural proteins that insert into the plasma membrane to form caveolae that can bind molecules important in cardiac signal transduction and function. Cytochrome P450 epoxygenases can metabolize arachidonic acid to epoxyeicosatrienoic acids (EETs) which have known cardioprotective effects. Subsequent metabolism of EETs by soluble epoxide hydrolase reduces the protective effect. (1) To assess the effect of ischemia-reperfusion injury on expression and subcellular localization of caveolins. (2) To study the effect of EETs on caveolins. Hearts from soluble epoxide hydrolase null (KO) and littermate control (WT) mice were perfused in Langendorff mode and subjected to 20 minutes ischemia followed by 40 minutes reperfusion. Immunohistochemistry, immunoblot, and electron microscopy were performed to study localization of caveolins and changes in ultrastructure. In WT heart, Cav-1 and Cav-3 were present in cardiomyocyte and capillary endothelial cell at baseline. After ischemia, Cav-1 but not Cav-3, disappeared from cardiomyocyte; moreover, caveolae were absent and mitochondrial cristae were damaged. Improved postischemic functional recovery observed in KO or WT hearts treated with 11,12-EET corresponded to higher Cav-1 expression and maintained caveolae structure. In addition, KO mice preserved the Cav-1 signaling after ischemia that lost in WT mice. Taken together, our data suggest that ischemia-reperfusion injury causes loss of Cav-1 and caveolins, and EETs-mediated cardioprotection involves preservation of Cav-1.Keywords
This publication has 18 references indexed in Scilit:
- Essential Role of Caveolin-3 in Adiponectin Signalsome Formation and Adiponectin CardioprotectionArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Caveolin-1 deficiency exacerbates cardiac dysfunction and reduces survival in mice with myocardial infarctionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Role of Caveolin-3 and Glucose Transporter-4 in Isoflurane-induced Delayed Cardiac ProtectionAnesthesiology, 2010
- Caveolin-1 exists and may function in cardiomyocytesCanadian Journal of Physiology and Pharmacology, 2010
- Cardiac-Specific Overexpression of Caveolin-3 Induces Endogenous Cardiac Protection by Mimicking Ischemic PreconditioningCirculation, 2008
- Caveolae as Organizers of Pharmacologically Relevant Signal Transduction MoleculesAnnual Review of Pharmacology and Toxicology, 2008
- Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injuryJournal of Molecular and Cellular Cardiology, 2008
- Redox regulation of ischemic preconditioning is mediated by the differential activation of caveolins and their association with eNOS and GLUT-4American Journal of Physiology-Heart and Circulatory Physiology, 2007
- Mechanisms of cardiac protection from ischemia/reperfusion injury: a role for caveolae and caveolin‐1The FASEB Journal, 2007
- Regional myocardial ischemia-induced activation of MAPKs is associated with subcellular redistribution of caveolin and cholesterolAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006